Clinical trial
Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating…
NCT00072124 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00072124 |
|---|---|
| Title | Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma |
| Official title | A Prospective Random Assignment Trial Comparing Complete Metastasectomy to Chemotherapy for Selected Patients With Stage IV Melanoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, dacarbazine, conventional surgery |
| Start date | Sep 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Nov 6, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: